Shanton Pharma New Jersey

Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001

View original content:https://www.prnewswire.co.uk/news-releases/shanton-screens-first-subjects-in-phase-2b-refractorytophaceous-gout-study-with-sap-001-301714878.html